Cancer Immunotherapy

Cited by (1,000)

Items 101–200 of 1,000

1. Clinical development of gene therapy: results and lessons from recent successes
   Sandeep R. P. Kumar, David M. Markusic, Moanaro Biswas, Katherine A. High, Roland W. Herzog · 2016 · Molecular Therapy — Methods & Clinical Development
2. VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
   Huang, Xing, Zhang, Xiaozhen, Li, Enliang, Zhang, Gang, Wang, Xun, Tang, Tianyu, Bai, Xueli, Liang, Tingbo · 2020 · Journal of Hematology & Oncology
3. Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
   Jinfang Zhang, Fabin Dang, Junming Ren, Wenyi Wei · 2018 · Trends in Biochemical Sciences
4. Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
   Cynthia L. Gay, Ronald J. Bosch, Justin Ritz, Jason M. Hataye, Evgenia Aga, Randall L. Tressler, Stephen W. Mason, Carey K. Hwang, Dennis M. Grasela, Neelanjana Ray et al. · 2017 · The Journal of Infectious Diseases
5. Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
   Shuhang Wang, Jingwei Sun, Kun Chen, Peiwen Ma, Qi Lei, Shujun Xing, Zhongzheng Cao, Shujun Sun, Zicheng Yu, Yarong Liu et al. · 2021 · BMC Medicine
6. Vaccine adjuvant uses of poly-IC and derivatives
   Karen A. O. Martins, Sina Bavari, Andres Μ. Salazar · 2014 · Expert Review of Vaccines
7. Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry
   Étienne Caron, Daniel Johannes Kowalewski, Ching Chiek Koh, Theo Sturm, Heiko Schuster, Ruedi H. Aebersold · 2015 · Molecular & Cellular Proteomics
8. Advancing to the era of cancer immunotherapy
   Yun Wang, Min Wang, Hao‐Xiang Wu, Rui‐Hua Xu · 2021 · 癌症：英文版
9. Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis
   Peter S. Linsley, Cate Speake, Elizabeth Whalen, Damien Chaussabel · 2014 · PLoS ONE
10. T Lymphocyte–Endothelial Interactions: Emerging Understanding of Trafficking and Antigen-Specific Immunity
    Christopher V. Carman, Roberta Martinelli · 2015 · Frontiers in Immunology
11. Advances in drug delivery for post-surgical cancer treatment
    Lin‐Lin Bu, Junjie Yan, Zejun Wang, Huitong Ruan, Qian Chen, Vivienne Gunadhi, R. Bryan Bell, Zhen Gu · 2019 · Biomaterials
12. Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia
    Xin He, Zijie Feng, Jian Ma, Sunbin Ling, Yan Hong Cao, Buddha Gurung, Yuan Wu, Bryson W. Katona, Kienan P. O’Dwyer, Don L. Siegel et al. · 2020 · Blood
13. CD70: An emerging target in cancer immunotherapy
    Julie Jacobs, Vanessa Deschoolmeester, Karen Zwaenepoel, Christian Diego Rolfo, Karen Silence, Sylvie Rottey, Filip Lardon, Evelien Smits, Patrick Pauwels · 2015 · Pharmacology & Therapeutics
14. mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma
    Wang, Yuhua, Zhang, Lu, Xu, Zhenghong, Miao, Lei, Huang, Leaf · 2018 · Molecular Therapy
15. B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade
    Sangwoo S. Kim, Sarek A. Shen, Sayuri Miyauchi, P. Dominick Sanders, Ida Franiak Pietryga, Loren K. Mell, Jorge Silvio Gutkind, Ezra E.W. Cohen, Joseph A. Califano, Andrew B. Sharabi · 2020 · Clinical Cancer Research
16. Recent Advances in Engineered Materials for Immunotherapy‐Involved Combination Cancer Therapy
    Jun‐Long Liang, Guo‐Feng Luo, Wei‐Hai Chen, Xian‐Zheng Zhang · 2021 · Advanced Materials
17. Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy
    Wei Li, Zehua Liu, Flavia Fontana, Yaping Ding, Dongfei Liu, Jouni J. Hirvonen, Hélder A. Santos · 2018 · Advanced Materials
18. Nanomaterial-Based Tumor Photothermal Immunotherapy
    Peng Xu, Feng Liang · 2020 · International Journal of Nanomedicine
19. CRISPR-Cas9: a new and promising player in gene therapy
    Xiao-Jie, Lu, Hui-Ying, Xue, Zun-Ping, Ke, Jin-Lian, Chen, Li-Juan, Ji · 2015 · Journal of Medical Genetics
20. Engineering Dendritic-Cell-Based Vaccines and PD-1 Blockade in Self-Assembled Peptide Nanofibrous Hydrogel to Amplify Antitumor T-Cell Immunity
    Pengxiang Yang, Huijuan Song, Yibo Qin, Pingsheng Huang, Chuangnian Zhang, Deling Kong, Weiwei Wang · 2018 · Nano Letters
21. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy
    Pingsheng Huang, Xiaoli Wang, Xiaoyu Liang, Jing Yang, Chuangnian Zhang, Deling Kong, Weiwei Wang · 2018 · Acta Biomaterialia
22. Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p
    Jie Xu, Qingtao Meng, Xiaobo Li, Hongbao Yang, Jin Xu, Na Gao, Hao Sun, Shenshen Wu, Giuseppe Familiari, Michela Relucenti et al. · 2019 · Cancer Research
23. Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
    Benoı̂t L. Salomon, Mathieu Leclerc, Jimena Tosello, Émilie Ronin, Eliane Piaggio, José Laurent Cohen · 2018 · Frontiers in Immunology
24. Immunomodulators targeting the PD‐1/PD‐L1 protein‐protein interaction: From antibodies to small molecules
    Jeffrey Yang, Longqin Hu · 2018 · Medicinal Research Reviews
25. Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice
    Julia A. Wagner, Dorothée Gößl, Natasha Ustyanovska Avtenyuk, Mengyao Xiong, Daniel Hauser, Olga Zhuzhgova, Sandra Hočevar, Betül Taşkoparan, Laura M. Poller, Stefan Datz et al. · 2021 · ACS Nano
26. Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer
    Yayi He, Christopher J. Rivard, Leslie M. Rozeboom, Hui Yu, Kim E. Ellison, Ashley A. Kowalewski, Caicun Zhou, Fred R. Hirsch · 2016 · Cancer Science
27. Immune checkpoint inhibitors: a promising anticancer therapy
    Sima Singh, Daniel Hassan, Hibah Mubarak Aldawsari, Nagashekhara Molugulu, Rahul Shukla, Prashant Kesharwani · 2019 · Drug Discovery Today
28. From monoclonal antibodies to small molecules: the development of inhibitors targeting the PD-1/PD-L1 pathway
    Meimiao Zhan, Xueqin Hu, Xiu-Xiu Liu, Ban‐Feng Ruan, Jun Xu, Chenzhong Liao · 2016 · Drug Discovery Today
29. The immunopeptidomic landscape of ovarian carcinomas
    Heiko Schuster, Janet K. Peper-Gabriel, Hans-Christian Bösmüller, Kevin Roehle, Linus Backert, Tatjana Bilich, Britta Ney, Markus W. Loeffler, Daniel Johannes Kowalewski, Nico Trautwein et al. · 2017 · Proceedings of the National Academy of Sciences
30. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines
    Glenn Kunnath Bonney, Claire Alexandra Zhen Chew, Peter A. Lodge, Joleen Marie Hubbard, Karim Jarir Halazun, Pavel Trunečka, Paolo Muiesan, Darius F. Mirza, John Isaac, Richard W. Laing et al. · 2021 · The Lancet. Gastroenterology & hepatology
31. New cell sources for T cell engineering and adoptive immunotherapy
    Themeli, Maria, Rivière, Isabelle, Sadelain, Michel · 2015 · Cell stem cell
32. Breaking the Depth Dependence by Nanotechnology‐Enhanced X‐Ray‐Excited Deep Cancer Theranostics
    Wenpei Fan, Wei Tang, Joseph Lau, Zheyu Shen, Jin Xie, Jianlin Shi, Xiaoyuan Shawn Chen · 2019 · Advanced Materials
33. Clinical and immunological effects of mRNA vaccines in malignant diseases
    Annkristin Heine, Stefan Juranek, Peter Brossart · 2021 · Molecular Cancer
34. mRNA-based dendritic cell vaccines
    Daphné Benteyn, Carlo Heirman, Aude Bonehill, Kris Thielemans, Karine Breckpot · 2014 · Expert Review of Vaccines
35. Nanomedicine-based tumor photothermal therapy synergized immunotherapy
    Tongyi Shang, Xinying Yu, Shisong Han, Bin Yang · 2020 · Biomaterials Science
36. Targeting the T-Cell Co-stimulatory CD27/CD70 Pathway in Cancer Immunotherapy: Rationale and Potential
    Koen van de Ven, Jannie G. Borst · 2015 · Immunotherapy
37. Delivery strategies of cancer immunotherapy: recent advances and future perspectives
    Zhongwei Zhao, Liyun Zheng, Weiqian Chen, Wei Weng, Jingjing Song, Jiansong Ji · 2019 · Journal of Hematology & Oncology
38. Immune Checkpoint Blockade Mediated by a Small‐Molecule Nanoinhibitor Targeting the PD‐1/PD‐L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer
    Rui Zhang, Zhiyan Zhu, Hongying Lv, Futian Li, Shuqing Sun, Juan Li, Chun‐Sing Lee · 2019 · Small
39. Sequencing the functional antibody repertoire—diagnostic and therapeutic discovery
    William H. Robinson · 2014 · Nature Reviews Rheumatology
40. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response
    Ruijing Liang, Jun Xie, Jun Li, Ke Wang, Liping Liu, Yujie Gao, Mubashir Hussain, Guanxin Shen, Jintao Zhu, Juan Tao · 2017 · Biomaterials
41. Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
    Jianbo Jia, Yi Zhang, Yan Xin, Cuijuan Jiang, Bing Yan, Shumei Zhai · 2018 · Frontiers in Oncology
42. Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy
    Wentao Xia, Zixuan Tao, Bin Zhu, Wenxiang Zhang, Chang Liu, Siyu Chen, Mingming Song · 2021 · International Journal of Molecular Sciences
43. Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities
    KM Morrissey, Theresa M. Yuraszeck, Chi‐Chung Li, Y Zhang, Sreeneeranj Kasichayanula · 2016 · Clinical and Translational Science
44. Redirection of Genetically Engineered CAR-T Cells Using Bifunctional Small Molecules
    Min Soo Kim, Jennifer S. Y. Ma, Hwayoung Yun, Yu J Cao, Ji Young Kim, Victor Chi, Danling Wang, Ashley C. Woods, Lance Sherwood, Dawna Caballero et al. · 2015 · Journal of the American Chemical Society
45. Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series
    Kim, Sang Taek, Tayar, Jean, Trinh, Van Anh, Suarez-Almazor, Maria, Garcia, Salvador, Hwu, Patrick, Johnson, Daniel Hartman, Uemura, Marc, Diab, Adi · 2017 · Annals of the Rheumatic Diseases
46. Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses
    Björn E. Clausen, Patrizia Stoitzner · 2015 · Frontiers in Immunology
47. Targets for immunotherapy of liver cancer
    Tim F. Greten, Bruno Sangro · 2017 · Journal of Hepatology
48. The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity
    Ludmila Danilova, Valsamo Anagnostou, Justina X. Caushi, John-William Sidhom, Haidan Guo, Hok Yee Chan, Prerna Suri, Ada J Tam, Jiajia Zhang, Margueritta El Asmar et al. · 2018 · Cancer Immunology Research
49. Tumorsphere as an effectivein vitroplatform for screening anti-cancer stem cell drugs
    Che‐Hsin Lee, Cheng‐Chia Yu, Bing‐Yen Wang, Wen‐Wei Chang · 2015 · Oncotarget
50. A Review of the Application of Inflammatory Biomarkers in Epidemiologic Cancer Research
    Darren R. Brenner, Dominique Scherer, Kenneth Ross Muir, Joellen M. Schildkraut, Paolo Boffetta, Margaret R. Spitz, Loïc Le Marchand, Andrew Tan Chan, Ellen L. Goode, Cornelia M. Ulrich et al. · 2014 · Cancer Epidemiology Biomarkers & Prevention
51. A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
    Samuel G. Awuah, Yao‐Rong Zheng, Peter M. Bruno, Michael T. Hemann, Stephen J. Lippard · 2015 · Journal of the American Chemical Society
52. Manganese-phenolic nanoadjuvant combines sonodynamic therapy with cGAS-STING activation for enhanced cancer immunotherapy
    Hao Tian, Guohao Wang, Wei Sang, Lisi Xie, Zhan Zhang, Wenxi Li, Jie Yan, Ye Tian, Jie Li, Bei Li et al. · 2022 · Nano Today
53. Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab
    Udupi Anantharamachar Ramagopal, Weifeng Liu, Sarah C. Garrett-Thomson, J.B. Bonanno, Qingrong Yan, Mohan Srinivasan, Susan C. Wong, Alasdair Bell, Shilpa Mankikar, Vangipuram S. Rangan et al. · 2017 · Proceedings of the National Academy of Sciences
54. Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
    Lu Tang, Zhongpei Huang, Heng Mei, Yu Hu · 2023 · Signal Transduction and Targeted Therapy
55. HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)
    Daniel Johannes Kowalewski, Heiko Schuster, Linus Backert, Claudia Berlin, Stefan Kahn, Lothar Kanz, Helmut Rainer Salih, Hans‐Georg Rammensee, Stefan Stevanović, Juliane Sarah Stickel · 2014 · Proceedings of the National Academy of Sciences
56. Nanogels for intracellular delivery of biotherapeutics
    Dandan Li, Cornelus F. van Nostrum, Enrico Mastrobattista, Tina Vermonden, Wim E. Hennink · 2016 · Journal of Controlled Release
57. Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors
    Amaury Leruste, Jimena Tosello, Rodrigo Nalio Ramos, Arnault Tauziède‐Espariat, Solène Brohard, Zhi‐Yan Han, Kévin Beccaria, Mamy Jean De Dieu Andrianteranagna, Pamela Caudana, Jovan Nikolić et al. · 2019 · Cancer Cell
58. Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation
    Hanchen Xu, Kevin Van der Jeught, Zhuolong Zhou, Lu Zhang, Tao Yu, Yifan Sun, Yujing Li, Changlin Wan, Ka Man So, Degang Liu et al. · 2021 · Journal of Clinical Investigation · Retracted
59. Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy
    Jun Xu, Hui Wang, Ligeng Xu, Yu Chao, Chenya Wang, Xiao Han, Ziliang Dong, Hong Chang, Rui Peng, Yiyun Cheng et al. · 2019 · Biomaterials
60. Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors
    Anja Derer, Benjamin Frey, Rainer Fietkau, Udo S. Gaipl · 2015 · Cancer Immunology Immunotherapy
61. Nanomedicine and macroscale materials in immuno-oncology
    Qingxue Sun, Matthias Barz, Bruno G. De Geest, Mustafa Diken, Wim E. Hennink, Fabian M. Kiessling, Twan Lammers, Yang Shi · 2018 · Chemical Society Reviews
62. Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer
    Ya Gao, Shuzhen Shi, Wenjuan Ma, Ji Chen, Yitong Cai, Long Ge, Lun Li, Jiarui Wu, Jinhui Tian · 2019 · International Immunopharmacology
63. Emerging therapies for non-small cell lung cancer
    Chao Zhang, Natasha B. Leighl, Yi-Long Lung Cancer Wu, Wen‐Zhao Zhong · 2019 · Journal of Hematology & Oncology
64. Inhibitory receptors as targets for cancer immunotherapy
    Meghan E. Turnis, Lawrence Peter Andrews, Dario A.A. Vignali · 2015 · European Journal of Immunology
65. Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy
    Xiangjun Tang, Xuyong Sun, Kuan-Ming Huang, Li Zhang, Zhuoshun Yang, Dandan Zou, Bin Wang, Garth L. Warnock, Long‐Jun Dai, Jie Denny Luo · 2015 · Oncotarget
66. Immunosurveillance and therapy of multiple myeloma are CD226 dependent
    Camille Guillerey, Lucas Ferrari de Andrade, Slavica Vučković, Kim M. Miles, Shin Foong Ngiow, Michelle C.R. Yong, Michele W.L. Teng, Marco Colonna, David S. Ritchie, Martha Chesi et al. · 2015 · Journal of Clinical Investigation
67. Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy
    Sébastien Anguille, Evelien Smits, Christian Edward Bryant, Heleen H. Van Acker, Herman Goossens, Eva Lion, Phillip D. Fromm, Derek N.J. Hart, Viggo F. Van Tendeloo, Zwi Nisan Berneman · 2015 · Pharmacological Reviews
68. Pasotuxizumab, a Bite ® Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings
    Hummel, Horst-Dieter, Kufer, Peter, Grüllich, Carsten, Seggewiss-Bernhardt, Ruth, Deschler-Baier, Barbara, Chatterjee, Manik, Goebeler, Maria-Elisabeth, Miller, Kurt, de Santis, Maria, Loidl, Wolfgang et al. · 2021 · Immunotherapy
69. Treg(s) in Cancer: Friends or Foe?
    Dominik Georg Friedrich Wolf, Sieghart Sopper, Andreas Pircher, Guenther A. Gastl, Anna Maria Wolf · 2015 · Journal of Cellular Physiology
70. Targeting the interleukin-17 immune axis for cancer immunotherapy
    Vitiello, Gerardo A., Miller, George · 2020 · Journal of Experimental Medicine
71. Melanoma Epidemiology and Prevention
    Marianne Berwick, David B. Buller, Anne Elizabeth Cust, Richard P. Gallagher, Tim K. Lee, Frank Louis Meyskens, Shaily Pandey, Nancy E. Thomas, Marit Bragelien Veierød, Sarah V. Ward · 2015 · Cancer treatment and research
72. The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines
    Toshifumi Doi, Takeshi Ishikawa, Tetsuya Okayama, Kaname Oka, Katsura Mizushima, Tomoyo Yasuda, Naoyuki Sakamoto, Kazuhiro Katada, Kazuhiro Kamada, Kazuhiko Uchiyama et al. · 2017 · Oncology Reports
73. Immune Checkpoint inhibitors: An introduction to the next‐generation cancer immunotherapy
    Lucy Lee, Manish Gupta, Srikumar Sahasranaman · 2015 · The Journal of Clinical Pharmacology
74. A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints
    Yongshu Li, Fangfei Li, Feng Jiang, Xiaoqing Lv, Rongjiang Zhang, Aiping Lü, Ge Zhang · 2016 · International Journal of Molecular Sciences
75. Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method
    Francesco A. Aprile, Pietro Sormanni, Michele Perni, Paolo Arosio, Sara Snogerup Linse, Tuomas P. J. Knowles, Christopher Martin Dobson, Michele Vendruscolo · 2017 · Science Advances
76. Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy
    Jingwei Sun, Lu Qiao, Miguel F. Sanmamed, Jun Wang · 2020 · Clinical Cancer Research
77. Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets
    Florian Wimmers, Gerty Schreibelt, Annette E. Sköld, Carl Gustav Figdor, I. Jolanda M. de Vries · 2014 · Frontiers in Immunology
78. Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma
    Ying Liu, Shengmeng Di, Bizhi Shi, Honghong Zhang, Yi Wang, Xiuqi Wu, Hong Luo, Huamao Wang, Zonghai Li, Hua Jiang · 2019 · The Journal of Immunology
79. mRNA vaccine in cancer therapy: Current advance and future outlook
    Youhuai Li, Mina Wang, Xueqiang Peng, Yingying Yang, Qishuang Chen, Jiaxing Liu, Qing She, Jichao Tan, Chuyuan Lou, Zehuan Liao et al. · 2023 · Clinical and Translational Medicine
80. Androgen deprivation and immunotherapy for the treatment of prostate cancer
    Melissa Gamat, Douglas G. McNeel · 2017 · Endocrine Related Cancer
81. Current Advances in T-Cell-Based Cancer Immunotherapy
    Mingjun Wang, Bingnan Yin, Helen Y. Wang, Rong‐Fu Wang · 2014 · Immunotherapy
82. Vascular normalisation as the stepping stone into tumour microenvironment transformation
    Magnussen, Anette L., Mills, Ian G. · 2021 · British Journal of Cancer
83. The emergence of drug resistance to targeted cancer therapies: Clinical evidence
    Ana Bela Sarmento‐Ribeiro, Andreas Scorilas, Ana Cristina Gonçalves, Thomas Efferth, Ioannis P. Trougakos · 2019 · Drug Resistance Updates
84. Photothermal-Activatable Fe 3 O 4 Superparticle Nanodrug Carriers with PD-L1 Immune Checkpoint Blockade for Anti-metastatic Cancer Immunotherapy
    Rui Ge, Cangwei Liu, Xue Zhang, Wenjing Wang, Binxi Li, Jie Liu, Yi Liu, Hongchen Sun, Daqi Zhang, Yuchuan Hou et al. · 2018 · ACS Applied Materials & Interfaces
85. Tumour microenvironment responsive nanoconstructs for cancer theranostic
    Arif Gulzar, Jiating Xu, Chen Wang, Fei He, Dan Yang, Shili Gai, Piaoping Yang, Jun Lin, Dayong Jin, Bengang Xing · 2019 · Nano Today
86. Tim-3, Lag-3, and TIGIT
    Nicole Joller, Vijay Kumar Kuchroo · 2017 · Current topics in microbiology and immunology
87. Creatine uptake regulates CD8 T cell antitumor immunity
    Di Biase, Stefano, Ma, Xiaoya, Wang, Xi, Yu, Jiaji, Wang, Yu-Chen, Smith, Drake J., Zhou, Yang, Li, Zhe, Kim, Yu Jeong, Clarke, Nicole et al. · 2019 · Journal of Experimental Medicine
88. Progress and perspective of microneedle system for anti-cancer drug delivery
    Dongdong Li, Doudou Hu, Hongxia Xu, Hirak Kumar Patra, Xiangrui Liu, Zhuxian Zhou, Jianbin Tang, Nigel K.H. Slater, Youqing Shen · 2020 · Biomaterials
89. A Phase II Randomized Clinical Trial and Mechanistic Studies Using Improved Probiotics to Prevent Oral Mucositis Induced by Concurrent Radiotherapy and Chemotherapy in Nasopharyngeal Carcinoma
    Chaofei Xia, Chunling Jiang, Wenyu Li, Jing Wei, Hu Hong, Jingao Li, Feng Liu, Hong Wei, Hongbo Xin, Tingtao Chen · 2021 · Frontiers in Immunology
90. Tim-3 expression and its role in hepatocellular carcinoma
    Feifei Liu, Yanning Liu, Zhi Chen · 2018 · Journal of Hematology & Oncology
91. Nanoscale Reduced Graphene Oxide-Mediated Photothermal Therapy Together with IDO Inhibition and PD-L1 Blockade Synergistically Promote Antitumor Immunity
    Mengmeng Yan, Yijia Liu, Xianghui Zhu, Xiaoli Wang, Lanxia Liu, Hongfan Sun, Chun Wang, Deling Kong, Guilei Ma · 2018 · ACS Applied Materials & Interfaces
92. YAP regulates PD-L1 expression in human NSCLC cells
    Jinbai Miao, Ping‐Chih Hsu, Yi‐Lin Yang, Zhidong Xu, Yuyuan Dai, Yucheng Wang, Geraldine Chan, Zhen Huang, Bin Hu, Hui Li et al. · 2017 · Oncotarget
93. Immunotherapeutic interventions of Triple Negative Breast Cancer
    Zehuan Li, Yiran Qiu, Weiqi Lu, Ying Jiang, Jin Wang · 2018 · Journal of Translational Medicine
94. The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer
    Kwan Ho Lee, Eun Young Kim, Ji‐Sup Yun, Yong Lai Park, Sung‐Im Do, Seoung Wan Chae, Chan Heun Park · 2018 · BMC Cancer
95. Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications
    Aitziber Buqué, Norma Bloy, Fernando Aranda, Francesca Castoldi, Alexander M.M. Eggermont, Isabelle Cremer, Wolf H. Fridman, Jitka Palich Fucikova, Jérôme Galon, Aurélien Marabelle et al. · 2015 · OncoImmunology
96. Inflammation lights the way to metastasis
    Seth B. Coffelt, Karin E. de Visser · 2014 · Nature
97. Chemotherapy and immunotherapy: mapping the road ahead
    Alistair Cook, Willem Joost Lesterhuis, Anna K. Nowak, Richard Lake · 2015 · Current Opinion in Immunology
98. Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study
    Simona Doniņa, Ieva Strēle, Guna Proboka · 2015 · Melanoma Research
99. OX40, PD‐1 and CTLA‐4 are selectively expressed on tumor‐infiltrating T cells in head and neck cancer
    Ryan D Montler, R. Bryan Bell, Colin Thalhofer, Rom S. Leidner, Zipei Feng, Bernard A. Fox, Allen C Cheng, Tuan Giang Bui, Christopher Tucker, Helena Maria Hoen et al. · 2016 · Clinical & Translational Immunology
100. The beginning of the end for conventional RECIST — novel therapies require novel imaging approaches
     Mirjam Gerwing, Ken Herrmann, Anne Helfen, Christoph Schliemann, Wolfgang E. Berdel, Michel Eisenblätter, Moritz Wildgruber · 2019 · Nature Reviews Clinical Oncology